GUADAGNI, FIORELLA
 Distribuzione geografica
Continente #
NA - Nord America 8.131
AS - Asia 5.793
EU - Europa 1.158
SA - Sud America 526
Continente sconosciuto - Info sul continente non disponibili 181
AF - Africa 104
OC - Oceania 17
Totale 15.910
Nazione #
US - Stati Uniti d'America 7.075
TR - Turchia 2.401
SG - Singapore 1.631
CN - Cina 1.270
CA - Canada 1.004
IT - Italia 611
BR - Brasile 439
EU - Europa 177
VN - Vietnam 173
IE - Irlanda 99
IN - India 94
DE - Germania 77
GB - Regno Unito 64
HK - Hong Kong 48
FI - Finlandia 44
ZA - Sudafrica 37
MX - Messico 34
RU - Federazione Russa 33
AR - Argentina 31
PL - Polonia 31
BD - Bangladesh 30
ES - Italia 30
JP - Giappone 30
ID - Indonesia 29
SC - Seychelles 29
FR - Francia 28
UA - Ucraina 26
NL - Olanda 21
RO - Romania 17
SE - Svezia 16
IQ - Iraq 15
EC - Ecuador 14
LT - Lituania 14
AU - Australia 13
SA - Arabia Saudita 11
MA - Marocco 10
CL - Cile 9
PK - Pakistan 9
PY - Paraguay 9
KR - Corea 8
CO - Colombia 7
VE - Venezuela 7
AE - Emirati Arabi Uniti 6
DK - Danimarca 5
KE - Kenya 5
BB - Barbados 4
CH - Svizzera 4
EG - Egitto 4
GR - Grecia 4
PE - Perù 4
PH - Filippine 4
SN - Senegal 4
TH - Thailandia 4
TN - Tunisia 4
TT - Trinidad e Tobago 4
UY - Uruguay 4
UZ - Uzbekistan 4
AZ - Azerbaigian 3
BA - Bosnia-Erzegovina 3
BE - Belgio 3
CZ - Repubblica Ceca 3
DZ - Algeria 3
HU - Ungheria 3
LB - Libano 3
NO - Norvegia 3
NZ - Nuova Zelanda 3
PT - Portogallo 3
SK - Slovacchia (Repubblica Slovacca) 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AL - Albania 2
BO - Bolivia 2
CR - Costa Rica 2
GT - Guatemala 2
JM - Giamaica 2
JO - Giordania 2
KW - Kuwait 2
KZ - Kazakistan 2
LV - Lettonia 2
MD - Moldavia 2
MY - Malesia 2
OM - Oman 2
XK - ???statistics.table.value.countryCode.XK??? 2
AD - Andorra 1
AO - Angola 1
AT - Austria 1
BG - Bulgaria 1
BH - Bahrain 1
BN - Brunei Darussalam 1
BY - Bielorussia 1
CG - Congo 1
CI - Costa d'Avorio 1
DO - Repubblica Dominicana 1
ET - Etiopia 1
GH - Ghana 1
HN - Honduras 1
IL - Israele 1
IR - Iran 1
KH - Cambogia 1
LA - Repubblica Popolare Democratica del Laos 1
LU - Lussemburgo 1
Totale 15.898
Città #
Kocaeli 2.103
San Mateo 1.619
Dallas 1.188
Toronto 960
Wilmington 464
Houston 425
Ashburn 392
Rome 386
Santa Clara 370
Beijing 353
Lawrence 322
Princeton 322
Singapore 299
Chandler 210
Seattle 132
Fairfield 129
Los Angeles 109
Woodbridge 101
Shanghai 99
Guangzhou 67
Ho Chi Minh City 63
Cambridge 55
Hong Kong 43
São Paulo 43
Hanoi 42
Brooklyn 41
Dublin 36
Helsinki 33
Shenzhen 32
Redwood City 31
New York 28
Warsaw 27
The Dalles 26
Tokyo 26
Chicago 24
Johannesburg 22
Columbus 21
Boston 17
Munich 17
Saint Petersburg 17
Wuhan 16
Council Bluffs 15
London 15
Quanzhou 15
Redmond 15
Mexico City 14
Milan 14
Montreal 14
Rio de Janeiro 14
Chennai 13
Jiaxing 13
Rui'an 12
Washington 12
Xi'an 12
Nanjing 11
Pune 11
Wuxi 11
Ankara 10
Atlanta 10
Kyiv 10
Mumbai 10
Phoenix 10
San Francisco 10
Bandung 9
Belo Horizonte 9
Pesaro 9
San Jose 9
Stockholm 9
Turku 9
Amsterdam 8
Bari 8
Curitiba 8
Dongyang 8
Frankfurt am Main 8
Jinhua 8
Taizhou 8
Haiphong 7
Nantong 7
Philadelphia 7
Vicenza 7
Xuzhou 7
Zhengzhou 7
Asunción 6
Campinas 6
Caxias do Sul 6
Changsha 6
Charlotte 6
Denver 6
Hefei 6
Jakarta 6
Rockville 6
Seoul 6
Thái Nguyên 6
Da Nang 5
Dhaka 5
Guayaquil 5
Jinan 5
Porto Alegre 5
Qingdao 5
Riyadh 5
Totale 11.234
Nome #
Angiogenesis and Hypertension: The Dual Role of Anti-Hypertensive and Anti-Angiogenic Therapies 122
Ketogenic Diet and Other Dietary Intervention Strategies in the Treatment of Cancer 120
RISK: A Random Optimization Interactive System Based on Kernel Learning for Predicting Breast Cancer Disease Progression 113
A Biospecimen Proficiency Testing Program for Biobank Accreditation: Four Years of Experience 110
A re-evaluation of carcinoembryonic antigen (CEA) as a serum marker for breast cancer: A prospective longitudinal study 99
Activation of blood coagulation in breast cancer - relationship to clinical outcome 98
A reliable and reproducible technique for DNA Fingerprinting in Biorepositories: A Pilot Study from BioBIM 92
Aging: an important risk factor in chemotherapy-associated vascular diseases 91
A Comprehensive Procedural Approach to Genotyping KRAS and BRAF from Paraffin Embedded Tissues for Diagnostic Purposes 90
An importance of identification of double variant methylenetetrahydrofolate reductase gene C677T and A1298C in cis configuration for pharmacogenetic studies 87
A Novel K-ras Mutation in Colorectal Cancer. A Case Report and Literature Review 87
Look beyond Catechol-O-Methyltransferase genotype for cathecolamines derangement in migraine: the BioBIM rs4818 and rs4680 polymorphisms study 84
Genetics of ischemic stroke, stroke-related risk factors, stroke precursors and treatments 84
Association between migraine and ACE gene (insertion/deletion) polymorphism: the BioBIM study 82
A global assay sensitive to activated protein C abnormalities is predictive for chemotherapy-associated venous thromboembolism 82
A NOVEL NONSENSE MUTATION IN KRAS GENE 82
TAG-72 (CA 72-4 ASSAY) AS A COMPLEMENTARY SERUM TUMOR-ANTIGEN TO CARCINOEMBRYONIC ANTIGEN IN MONITORING PATIENTS WITH COLORECTAL-CANCER 82
An AT-Rich Region in the APC Gene May Cause Misinterpretation of Familial Adenomatous Polyposis Molecular Screening 82
A Simple and Effective Method to Analyze Membrane Proteins by SDS-PAGE and MALDI Mass Spectrometry 81
A METASTATIC NUDE-MOUSE MODEL OF HUMAN PANCREATIC-CANCER CONSTRUCTED ORTHOTOPICALLY WITH HISTOLOGICALLY INTACT PATIENT SPECIMENS 78
A new human tumor-associated antigen (TLP) is naturally expressed in rat DHD-K12 colorectal tumor cells 78
An activated protein C-dependent thrombin generation assay predicts chemotherapy-associated venous thromboembolism in cancer patients 76
CARCINOEMBRYONIC ANTIGEN REGULATION IN HUMAN COLORECTAL TUMOR-CELLS BY A SITE-SELECTIVE CYCLIC-AMP ANALOG - A COMPARISON WITH INTERFERON-GAMMA 76
Age-Dependent Levels of Protein Kinase Cs in Brain: Reduction of Endogenous Mechanisms of Neuroprotection 75
TAG-72 expression and its role in the biological evaluation of human colorectal cancer 74
BIOLOGIC EVALUATION OF TUMOR-ASSOCIATED GLYCOPROTEIN-72 AND CARCINOEMBRYONIC ANTIGEN EXPRESSION IN COLORECTAL-CANCER .1 72
Neutrophil/lymphocyte ratio helps select metastatic pancreatic cancer patients benefitting from oxaliplatin 69
"Proteomineering" or not? The debate on biomarker discovery in sera continues 68
Analysis of chromosomes 3, 7, X and the EGFR gene in uterine cervical cancer progression 68
Age-related reduction of cerebral ischemic preconditioning: myth or reality? 67
Inherited coagulation disorders in cirrhotic patients with and without portal vein trhombosis (PVT) 65
Association between migraine and sod1 and sod2 genes polymorphisms: the biobim study 65
MAINTENANCE OF EXPRESSION OF TUMOR-ANTIGENS IN 3-DIMENSIONAL INVITRO HUMAN TUMOR GEL-SUPPORTED HISTOCULTURE 64
ROLE OF TUMOR-CELL MEMBRANE GANGLIOSIDES IN PROMOTING PLATELET PROAGGREGATING ACTIVITY 64
VEGF gene promoter polymorphisms and risk of VTE in chemotherapy-treated cancer patients 62
“Personal and sensitive data in the e-health-IoT universe” 62
PD-L1 Is Highly Expressed in Malignant Mesothelioma and PD-1(+)Lymphocytes within Malignant Effusions Induce PD-L1 Expression 61
Role of interleukin-6 in the diagnosis of acute aortic dissection 61
CORRELATION BETWEEN POSITIVE CA-72-4 SERUM LEVELS AND LYMPH-NODE INVOLVEMENT IN PATIENTS WITH GASTRIC-CARCINOMA 61
PLATELET PROAGGREGATING ACTIVITY OF HUMAN COLORECTAL TUMOR-CELL LINES DOES NOT CORRELATE WITH THE DEGREE OF DIFFERENTIATION 61
Tumor markers as targets for selective diagnostic and therapeutic procedures 61
MUTATIONAL ANALYSIS IN INHERITED BREAST/OVARIAN CANCER PATIENTS FROM CENTRAL ITALY REGINA ELENA CANCER INSTITUTE OF ROME, ITALY 61
Impact of chemotherapy on activated protein C-dependent thrombin generation - association with venous thromboembolism occurrence 61
Protective Effect of Antioxidants in Nitric Oxide/COX-2 Interaction during Inflammatory Pain: The Role of Nitration 61
Correlation between soluble CD40 ligand, VEGF plasma levels and haemostatic activation in non-small cell lung cancer (NSCLC) 60
Recombinant interferon enhances monoclonal antibody-targeting of carcinoma lesions in vivo 60
EVALUATION OF TAG-72 (CA-72-4) SERUM MARKER IN PRIMARY DIAGNOSIS IN OVARIAN-CANCER - A COMPARISON WITH CA-125 60
Correlations between phenotype and microsatellite instability in HNPCC: implications for genetic testing 60
Detection of blood-borne cells in colorectal cancer patients by nested reverse transcription-polymerase chain reaction for carcinoembryonic antigen messenger RNA: Longitudinal analyses and demonstration of its potential importance as an adjunct to multiple serum markers 59
In vitro interactions between blood platelets and human colorectal tumor cells 58
Intraoperative radioimmunolocalization of an anti-CEA MAb F(Ab')(2) (F023C5) in CEA serum-negative colorectal cancer patients 58
Association between carcinoembryonic antigen and vascular endothelial growth factor tumor tissue content of colorectal cancer 58
BIOLOGIC AND CLINICAL CORRELATIONS AMONG PLOIDY, CELL-KINETICS, AND THE TUMOR-ASSOCIATED GLYCOPROTEIN-72 TISSUE EXPRESSION IN COLORECTAL-CANCER - PRELIMINARY FINDINGS 58
Trombofilia ereditaria e poliabortività: studio osservazionale in 150 pazienti 58
Risk Assessment for Venous Thromboembolism in Chemotherapy-Treated Ambulatory Cancer Patients 58
Association of low-grade inflammation and platelet activation in patients with hypertension with microalbuminuria 58
PAI-1 4G/5G repeat is a target in gastric carcinomas with microsatellite instability 58
Influence of interferon on the functional expression of natural killer target structures of murine lymphoma cells 58
Artificial intelligence for cancer-associated thrombosis risk assessment 58
Impact of deleterious variants in other genes beyond BRCA1/2 detected in breast/ovarian and pancreatic cancer patients by NGS-based multi-gene panel testing: looking over the hedge 58
Is CEA serum measurement useful in monitoring breast cancer patients? 57
TARGETING ANTIBODIES TO LIVE TUMOR-TISSUE IN 3-D HISTOCULTURE 57
Quantitative analysis of CEA expression in colorectal adenocarcinoma and serum: Lack of correlation 57
The pharmacokinetic profile of levodopa administered with and without tolcapone in patients with advanced PD 57
Contribution of platelet-derived CD40 ligand to inflammation, thrombosis and neoangiogenesis 57
Machine learning approach to predict medication overuse in migraine patients 57
Towards the Interpretability of Machine Learning Predictions for Medical Applications Targeting Personalised Therapies: A Cancer Case Survey 57
Effect of 5-fluorouracil on carcinoembryonic antigen expression and shedding at clonal level in colon cancer cells 56
Random optimization interactive system based on Kernel learning (RISK) for venous thromboembolism risk assessment in chemotherapy-treated cancer patients 56
Soluble CD40 ligand (sCD40L) plasma levels in non-small cell lung cancer 56
Sentinel lymphadenectomy in cutaneous melanoma 56
Evaluation of the CA 242 tumor antigen as a potential serum marker for colorectal cancer 56
Ideal Body Mass Index (BMI) is significantly different between curatively resected and metastatic colorectal cancer (CRC) patients on chemotherapy 56
Circulating Biomarkers in Migraine: New Opportunities for Precision Medicine 56
Dopaminergic symptoms in migraine: A cross-sectional study on 1148 consecutive headache center-based patients 56
Predicting VTE in Cancer Patients: Candidate Biomarkers and Risk Assessment Models 56
SERUM LEPTIN LEVELS IN COLORECTAL CANCER PATIENTS 55
TNFA Gene Promoter Polymorphisms and Susceptibility to Recurrent Pregnancy Loss in Italian Women 55
High-sensitive D-dimer Determination for the Prediction of Chemotherapy-associated Venous Thromboembolism in Lung Cancer Patients 55
Venous thromboembolism risk prediction in ambulatory cancer patients: Clinical significance of neutrophil/lymphocyte ratio and platelet/lymphocyte ratio 55
Platinum-based compounds and risk for cardiovascular toxicity in the elderly: role of the antioxidants in chemoprevention 55
The insulin-glucose axis in breast cancer - relationship to clinical outcome 54
Metabolic Syndrome (MetS) in Metastatic (m) Colorectal Cancer (CRC) Patients (pts) Might Delay the Onset of Cachexia 54
In vivo platelet activation is responsible for enhanced vascular endothelial growth factor levels in hypertensive patients 54
Biomarkers of platelet activation in acute coronary syndromes 54
Clinical value of radiolabeled monoclonal antibodies in the management of carcinoma patients 54
CA 19-9 monosialoganglioside content of human colorectal tumor cells correlates with tumor cell-induced platelet aggregation 54
Induction of protective host immunity to carcinoembryonic antigen (CEA), a self-antigen in CEA transgenic mice, by immunizing with a recombinant vaccinia-CEA virus 54
TUMOR-ASSOCIATED GLYCOPROTEIN-72 SERUM LEVELS COMPLEMENT CARCINOEMBRYONIC ANTIGEN LEVELS IN MONITORING PATIENTS WITH GASTROINTESTINAL CARCINOMA - A LONGITUDINAL-STUDY 54
Role of Serum and Glucocorticoid-Inducible Kinase (SGK)-1 in Senescence: A Novel Molecular Target Against Age-Related Diseases 54
Plasma Plasminogen Activator Inhibitor-1 (PAI-1) Levels in Breast Cancer - Relationship with Clinical Outcome 54
Circulating Levels of Pro-Inflammatory Cytokines in Isolated Limb Perfusion 53
Soluble E-selectin levels and CEA expressing blood-borne cells in colorectal cancer patients. A causal relationship? 53
Status of the p53, p16, RB1, and HER-2 genes and chromosomes 3, 7, 9, and 17 in advanced bladder cancer: correlation with adjacent mucosa and pathological parameters 53
CLINICAL-EVALUATION OF THE NEW TUMOR-MARKER TAG-72 53
Assays for Qualification and Quality Stratification of Clinical Biospecimens Used in Research: A Technical Report from the ISBER Biospecimen Science Working Group 53
BRCA1 and BRCA2 mutations in central and southern Italian patients 53
Breast Cancer Prognosis Using a Machine Learning Approach 53
BRCA1 and BRCA2 mutational analysis in inherited breast/ovarian cancer patients from central Italy 52
Association between Migraine and Progesterone Receptor Gene PROGINS Polymorphism: the BioBIM study 52
Totale 6.569
Categoria #
all - tutte 165.277
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 165.277


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20212.799 0 0 0 0 0 148 95 55 99 59 2.113 230
2021/20223.140 19 961 966 5 4 6 348 352 47 389 5 38
2022/20231.172 703 24 17 70 49 13 7 53 41 81 110 4
2023/2024710 6 2 21 152 36 48 15 35 0 63 5 327
2024/20252.898 158 642 144 110 162 499 197 145 325 20 80 416
2025/20264.008 534 751 922 475 517 809 0 0 0 0 0 0
Totale 16.377